| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Replicative senescence of mesenchymal stem cells: a continuous and organized process.
|
PLoS One
|
2008
|
4.37
|
|
2
|
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.
|
Exp Hematol
|
2005
|
4.27
|
|
3
|
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.
|
Blood
|
2009
|
3.07
|
|
4
|
DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells.
|
Aging Cell
|
2009
|
2.84
|
|
5
|
Aging and replicative senescence have related effects on human stem and progenitor cells.
|
PLoS One
|
2009
|
2.62
|
|
6
|
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity.
|
Blood
|
2004
|
2.61
|
|
7
|
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.
|
Lancet Oncol
|
2007
|
2.44
|
|
8
|
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.
|
Blood
|
2011
|
2.37
|
|
9
|
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
|
Lancet Oncol
|
2008
|
2.34
|
|
10
|
Targeting the BRAF V600E mutation in multiple myeloma.
|
Cancer Discov
|
2013
|
2.32
|
|
11
|
BRAF inhibition in refractory hairy-cell leukemia.
|
N Engl J Med
|
2012
|
2.25
|
|
12
|
Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis.
|
Int J Cardiol
|
2011
|
2.10
|
|
13
|
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system.
|
Blood
|
2011
|
1.97
|
|
14
|
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
|
Blood
|
2010
|
1.94
|
|
15
|
Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging.
|
Blood
|
2011
|
1.92
|
|
16
|
Mesenchymal stem cell preparations--comparing apples and oranges.
|
Stem Cell Rev
|
2007
|
1.88
|
|
17
|
Suppression of T-cell functions by human granulocyte arginase.
|
Blood
|
2006
|
1.85
|
|
18
|
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
|
J Clin Oncol
|
2013
|
1.84
|
|
19
|
Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
|
J Am Coll Cardiol
|
2012
|
1.84
|
|
20
|
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
|
J Clin Oncol
|
2011
|
1.84
|
|
21
|
Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen.
|
Cancer Res
|
2007
|
1.69
|
|
22
|
Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells.
|
Blood
|
2002
|
1.65
|
|
23
|
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.
|
Blood
|
2011
|
1.65
|
|
24
|
Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction.
|
Stem Cells
|
2005
|
1.62
|
|
25
|
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.
|
J Clin Oncol
|
2010
|
1.60
|
|
26
|
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.
|
J Clin Oncol
|
2013
|
1.60
|
|
27
|
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation.
|
Haematologica
|
2010
|
1.58
|
|
28
|
Modeling of asymmetric cell division in hematopoietic stem cells--regulation of self-renewal is essential for efficient repopulation.
|
Stem Cells Dev
|
2009
|
1.57
|
|
29
|
Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET.
|
Leuk Lymphoma
|
2007
|
1.53
|
|
30
|
Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis.
|
Blood
|
2004
|
1.51
|
|
31
|
Different facets of aging in human mesenchymal stem cells.
|
Tissue Eng Part B Rev
|
2010
|
1.51
|
|
32
|
Specific age-associated DNA methylation changes in human dermal fibroblasts.
|
PLoS One
|
2011
|
1.51
|
|
33
|
Induction of CD4+ T-cell anergy and apoptosis by activated human B cells.
|
Blood
|
2008
|
1.49
|
|
34
|
Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy.
|
Leuk Lymphoma
|
2010
|
1.49
|
|
35
|
Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors.
|
Stem Cells
|
2007
|
1.45
|
|
36
|
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
|
Ann Hematol
|
2007
|
1.44
|
|
37
|
The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma.
|
Leuk Lymphoma
|
2011
|
1.44
|
|
38
|
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.
|
Blood
|
2006
|
1.43
|
|
39
|
Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1.
|
J Cell Biol
|
2009
|
1.41
|
|
40
|
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma.
|
Leuk Lymphoma
|
2008
|
1.40
|
|
41
|
Proteins required for centrosome clustering in cancer cells.
|
Sci Transl Med
|
2010
|
1.35
|
|
42
|
The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomes.
|
Exp Hematol
|
2006
|
1.35
|
|
43
|
GSK-3 mediates differentiation and activation of proinflammatory dendritic cells.
|
Blood
|
2006
|
1.34
|
|
44
|
DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function.
|
Cell Cycle
|
2007
|
1.34
|
|
45
|
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.
|
Blood
|
2011
|
1.30
|
|
46
|
Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells.
|
J Cell Mol Med
|
2009
|
1.25
|
|
47
|
Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.
|
Blood
|
2007
|
1.24
|
|
48
|
Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells.
|
Cytotherapy
|
2010
|
1.23
|
|
49
|
Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction.
|
Exp Hematol
|
2007
|
1.17
|
|
50
|
Population dynamics of mesenchymal stromal cells during culture expansion.
|
Cytotherapy
|
2011
|
1.16
|
|
51
|
N-cadherin is expressed on human hematopoietic progenitor cells and mediates interaction with human mesenchymal stromal cells.
|
Stem Cell Res
|
2010
|
1.16
|
|
52
|
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
|
Br J Haematol
|
2013
|
1.16
|
|
53
|
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
|
Exp Hematol
|
2006
|
1.14
|
|
54
|
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.
|
Haematologica
|
2010
|
1.14
|
|
55
|
Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
1.14
|
|
56
|
Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.
|
Biol Blood Marrow Transplant
|
2011
|
1.13
|
|
57
|
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.
|
Blood
|
2008
|
1.12
|
|
58
|
Role of histone deacetylase inhibitors in the treatment of cancer (Review).
|
Int J Oncol
|
2004
|
1.12
|
|
59
|
Aging of hematopoietic stem cells is regulated by the stem cell niche.
|
Exp Gerontol
|
2008
|
1.12
|
|
60
|
Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
|
Eur J Haematol
|
2010
|
1.11
|
|
61
|
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
|
Br J Haematol
|
2004
|
1.11
|
|
62
|
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
|
Haematologica
|
2008
|
1.09
|
|
63
|
Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
|
Exp Hematol
|
2009
|
1.08
|
|
64
|
Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism.
|
Stem Cells
|
2006
|
1.07
|
|
65
|
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.
|
Haematologica
|
2007
|
1.06
|
|
66
|
Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.
|
J Immunol
|
2007
|
1.06
|
|
67
|
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma.
|
Br J Haematol
|
2014
|
1.06
|
|
68
|
Advances in mobilization for the optimization of autologous stem cell transplantation.
|
Leuk Lymphoma
|
2009
|
1.05
|
|
69
|
Mycobacterium kansasii tenosynovitis in a rheumatoid arthritis patient with long-term therapeutic immunosuppression.
|
Arthritis Rheum
|
2008
|
1.05
|
|
70
|
Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1.
|
Immunol Cell Biol
|
2007
|
1.04
|
|
71
|
Evaluation of mineralized collagen and alpha-tricalcium phosphate as scaffolds for tissue engineering of bone using human mesenchymal stem cells.
|
Cells Tissues Organs
|
2004
|
1.03
|
|
72
|
Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.
|
J Clin Oncol
|
2013
|
1.03
|
|
73
|
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
|
Clin Cancer Res
|
2007
|
1.03
|
|
74
|
Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group.
|
J Cell Mol Med
|
2009
|
1.03
|
|
75
|
Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
|
J Immunother
|
2006
|
1.03
|
|
76
|
Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division.
|
Blood
|
2005
|
1.02
|
|
77
|
Chk1-dependent regulation of Cdc25B functions to coordinate mitotic events.
|
Cell Cycle
|
2006
|
1.02
|
|
78
|
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma.
|
J Immunol
|
2011
|
1.02
|
|
79
|
Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells.
|
Cell Tissue Res
|
2007
|
1.02
|
|
80
|
Adipogenic differentiation of human mesenchymal stromal cells is down-regulated by microRNA-369-5p and up-regulated by microRNA-371.
|
J Cell Physiol
|
2011
|
1.01
|
|
81
|
Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology.
|
Br J Haematol
|
2011
|
1.01
|
|
82
|
Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.
|
Ann Hematol
|
2008
|
1.01
|
|
83
|
Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany.
|
J Clin Microbiol
|
2012
|
1.00
|
|
84
|
Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseases.
|
Psychosom Med
|
2004
|
1.00
|
|
85
|
Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.
|
Clin Cancer Res
|
2002
|
1.00
|
|
86
|
Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma.
|
Int J Cancer
|
2006
|
1.00
|
|
87
|
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells.
|
Blood
|
2004
|
0.99
|
|
88
|
Intravitreal autologous bone-marrow-derived mononuclear cell transplantation.
|
Acta Ophthalmol
|
2009
|
0.99
|
|
89
|
Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression.
|
Int J Cancer
|
2003
|
0.99
|
|
90
|
The Stromal Activity of Mesenchymal Stromal Cells.
|
Transfus Med Hemother
|
2008
|
0.98
|
|
91
|
Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells.
|
Cardiovasc Res
|
2007
|
0.97
|
|
92
|
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients.
|
Cancer
|
2013
|
0.96
|
|
93
|
Clinicopathologic correlations of genomic gains and losses in follicular lymphoma.
|
J Clin Oncol
|
2002
|
0.96
|
|
94
|
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
|
J Clin Oncol
|
2013
|
0.96
|
|
95
|
Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment.
|
Biol Blood Marrow Transplant
|
2012
|
0.96
|
|
96
|
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).
|
J Clin Oncol
|
2013
|
0.96
|
|
97
|
Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay.
|
Blood
|
2010
|
0.95
|
|
98
|
Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene.
|
Int J Oncol
|
2006
|
0.95
|
|
99
|
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo.
|
Cancer Res
|
2012
|
0.95
|
|
100
|
In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
|
Exp Hematol
|
2011
|
0.95
|
|
101
|
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
|
Eur J Haematol
|
2006
|
0.94
|
|
102
|
Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile.
|
Blood
|
2002
|
0.94
|
|
103
|
Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.
|
Mol Ther
|
2009
|
0.94
|
|
104
|
Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells.
|
Exp Hematol
|
2011
|
0.94
|
|
105
|
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone.
|
Cancer
|
2010
|
0.94
|
|
106
|
Centrosome aberrations in hematological malignancies.
|
Cell Biol Int
|
2005
|
0.94
|
|
107
|
Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes.
|
Oncogene
|
2004
|
0.93
|
|
108
|
The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment.
|
Exp Hematol
|
2003
|
0.93
|
|
109
|
Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44.
|
Cells Tissues Organs
|
2007
|
0.93
|
|
110
|
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
|
Cancer
|
2007
|
0.92
|
|
111
|
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
|
Cancer Invest
|
2006
|
0.92
|
|
112
|
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
|
Mar Drugs
|
2009
|
0.92
|
|
113
|
Regulation of NK cell function by human granulocyte arginase.
|
J Immunol
|
2009
|
0.92
|
|
114
|
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.
|
Exp Hematol
|
2006
|
0.92
|
|
115
|
Sarcoidosis and the occurrence of malignant diseases.
|
Rheumatol Int
|
2014
|
0.92
|
|
116
|
Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report.
|
Acta Ophthalmol
|
2007
|
0.91
|
|
117
|
The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
|
Leuk Res
|
2005
|
0.91
|
|
118
|
Chromosomal organization and localization of the novel class IV human histone deacetylase 11 gene.
|
Int J Mol Med
|
2005
|
0.91
|
|
119
|
Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
|
Transfusion
|
2007
|
0.90
|
|
120
|
Leukemia stem cells.
|
Int J Cancer
|
2011
|
0.90
|
|
121
|
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.
|
Ann Hematol
|
2008
|
0.90
|
|
122
|
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells.
|
Clin Cancer Res
|
2011
|
0.89
|
|
123
|
Complementary and alternative medicine in patients with chronic lymphocytic leukemia.
|
Support Care Cancer
|
2008
|
0.89
|
|
124
|
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).
|
Blood
|
2011
|
0.89
|
|
125
|
P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.
|
Int J Cancer
|
2002
|
0.88
|
|
126
|
Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment.
|
Ann Hematol
|
2010
|
0.88
|
|
127
|
Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cells.
|
Exp Hematol
|
2002
|
0.88
|
|
128
|
Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals.
|
Blood
|
2006
|
0.87
|
|
129
|
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
|
Haematologica
|
2006
|
0.87
|
|
130
|
The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells.
|
J Biomed Biotechnol
|
2007
|
0.87
|
|
131
|
Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone.
|
Amyloid
|
2014
|
0.86
|
|
132
|
Modeling SDF-1-induced mobilization in leukemia cell lines.
|
Exp Hematol
|
2012
|
0.86
|
|
133
|
Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.
|
Blood
|
2002
|
0.86
|
|
134
|
Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells.
|
Cancer Immunol Immunother
|
2007
|
0.86
|
|
135
|
Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse.
|
J R Soc Interface
|
2014
|
0.86
|
|
136
|
Mesenchymal stromal cells (MSCs): science and f(r)iction.
|
J Mol Med (Berl)
|
2012
|
0.85
|
|
137
|
FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2).
|
Int J Oncol
|
2005
|
0.85
|
|
138
|
Shear stress regulates adhesion and rolling of CD44+ leukemic and hematopoietic progenitor cells on hyaluronan.
|
Biophys J
|
2011
|
0.85
|
|
139
|
Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance.
|
Exp Hematol
|
2011
|
0.85
|
|
140
|
Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.
|
Haematologica
|
2012
|
0.85
|
|
141
|
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
|
Br J Haematol
|
2003
|
0.84
|
|
142
|
Retroviral integration sites correlate with expressed genes in hematopoietic stem cells.
|
Stem Cells
|
2005
|
0.84
|
|
143
|
Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells.
|
Int J Cancer
|
2004
|
0.84
|
|
144
|
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
|
BMC Cancer
|
2011
|
0.84
|
|
145
|
Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease.
|
Haematologica
|
2012
|
0.84
|
|
146
|
Arginine deficiency leads to impaired cofilin dephosphorylation in activated human T lymphocytes.
|
Int Immunol
|
2012
|
0.83
|
|
147
|
Identifying leukemia stem cells--is it feasible and does it matter?
|
Cancer Lett
|
2012
|
0.83
|
|
148
|
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
|
Onkologie
|
2008
|
0.83
|
|
149
|
Gemcitabine and docetaxel for metastatic soft tissue sarcoma - a single center experience.
|
Onkologie
|
2013
|
0.83
|
|
150
|
Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis.
|
Transplantation
|
2005
|
0.83
|
|
151
|
Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
|
Biotechnol J
|
2012
|
0.83
|
|
152
|
T cell-based targeted immunotherapies for patients with multiple myeloma.
|
Int J Cancer
|
2014
|
0.83
|
|
153
|
Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone disease.
|
Haematologica
|
2008
|
0.83
|
|
154
|
IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production.
|
Biochem Pharmacol
|
2010
|
0.82
|
|
155
|
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.
|
Haematologica
|
2006
|
0.82
|
|
156
|
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis.
|
Eur J Heart Fail
|
2009
|
0.82
|
|
157
|
Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6.
|
Blood
|
2013
|
0.82
|
|
158
|
Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma.
|
Int J Cancer
|
2007
|
0.82
|
|
159
|
Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
|
Clin Lymphoma Myeloma
|
2005
|
0.81
|
|
160
|
Resistance of polysaccharide coatings to proteins, hematopoietic cells, and marine organisms.
|
Biomacromolecules
|
2009
|
0.81
|
|
161
|
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
|
J Immunother
|
2009
|
0.81
|
|
162
|
Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experience.
|
Eur J Haematol
|
2014
|
0.81
|
|
163
|
Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting.
|
Biol Blood Marrow Transplant
|
2010
|
0.81
|
|
164
|
Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2002
|
0.81
|
|
165
|
Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma.
|
Exp Hematol
|
2012
|
0.81
|
|
166
|
Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma.
|
Transfusion
|
2014
|
0.81
|
|
167
|
Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters.
|
Cancer
|
2002
|
0.81
|
|
168
|
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma.
|
Int J Cancer
|
2008
|
0.81
|
|
169
|
Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor.
|
Cytotherapy
|
2010
|
0.80
|
|
170
|
Differential survival of AML subpopulations in NOD/SCID mice.
|
Exp Hematol
|
2010
|
0.80
|
|
171
|
Primitive and committed human hematopoietic progenitor cells interact with primary murine neural cells and are induced to undergo self-renewing cell divisions.
|
Exp Hematol
|
2007
|
0.80
|
|
172
|
Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.
|
Oncology
|
2008
|
0.80
|
|
173
|
No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.
|
Nephrol Dial Transplant
|
2003
|
0.80
|
|
174
|
Innovative method for quantification of cell-cell adhesion in 96-well plates.
|
Cell Adh Migr
|
2011
|
0.79
|
|
175
|
One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
|
Leuk Res
|
2006
|
0.79
|
|
176
|
Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiation.
|
Strahlenther Onkol
|
2014
|
0.79
|
|
177
|
Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A).
|
Ann Hematol
|
2006
|
0.79
|
|
178
|
Suppression of cytomegalovirus-specific CD8(+)T cells by everolimus.
|
Leuk Lymphoma
|
2013
|
0.79
|
|
179
|
CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantation.
|
ScientificWorldJournal
|
2012
|
0.79
|
|
180
|
Risk factors for AA amyloidosis in Germany.
|
Amyloid
|
2014
|
0.79
|
|
181
|
Lack of evidence for inhibition of angiogenesis as a central mechanism of the antiarthritic effect of methotrexate.
|
Rheumatol Int
|
2003
|
0.78
|
|
182
|
Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantation.
|
Transplantation
|
2015
|
0.78
|
|
183
|
Is there an indication for high-dose chemotherapy in the treatment of bone and soft-tissue sarcoma?
|
Oncology
|
2005
|
0.78
|
|
184
|
Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
|
Ann Hematol
|
2007
|
0.78
|
|
185
|
Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy.
|
Eur J Haematol
|
2010
|
0.78
|
|
186
|
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma.
|
Eur J Haematol
|
2004
|
0.78
|
|
187
|
High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statin therapy.
|
Haematologica
|
2013
|
0.78
|
|
188
|
Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia.
|
Methods Mol Biol
|
2013
|
0.78
|
|
189
|
Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletion.
|
PLoS One
|
2013
|
0.78
|
|
190
|
A new therapeutic approach in patients with advanced sarcoma.
|
Int J Clin Oncol
|
2005
|
0.77
|
|
191
|
Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia.
|
Leuk Lymphoma
|
2014
|
0.77
|
|
192
|
Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myeloma.
|
J Clin Apher
|
2014
|
0.77
|
|
193
|
Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.
|
Mar Drugs
|
2010
|
0.77
|
|
194
|
Quantitative real-time polymerase chain reaction shows that treatment with interferon reduces the initially upregulated PRV-1 expression in polycythemia vera patients.
|
Haematologica
|
2003
|
0.77
|
|
195
|
Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
|
Stem Cells
|
2007
|
0.77
|
|
196
|
Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells.
|
J Autoimmun
|
2012
|
0.77
|
|
197
|
Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma.
|
Future Oncol
|
2008
|
0.77
|
|
198
|
Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
|
Cancer
|
2012
|
0.76
|
|
199
|
Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells.
|
Cancer Chemother Pharmacol
|
2009
|
0.76
|
|
200
|
Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
|
Am J Hematol
|
2003
|
0.76
|
|
201
|
High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.
|
Int J Cancer
|
2007
|
0.76
|
|
202
|
The oral histone deacetylase inhibitor LBH589 is a potential and promising therapeutic agent in multiple myeloma after at least two lines of chemotherapy including bortezomib or lenalidomide.
|
Onkologie
|
2010
|
0.76
|
|
203
|
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study.
|
Ann Hematol
|
2014
|
0.76
|
|
204
|
Human eosinophil granulocytes do not express the enzyme arginase.
|
J Leukoc Biol
|
2010
|
0.76
|
|
205
|
Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells.
|
Stem Cells
|
2007
|
0.76
|
|
206
|
Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.
|
Leuk Lymphoma
|
2014
|
0.76
|
|
207
|
Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg.
|
Dig Dis
|
2006
|
0.76
|
|
208
|
Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.
|
Ann Hematol
|
2003
|
0.76
|
|
209
|
Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor.
|
Case Rep Oncol
|
2009
|
0.75
|
|
210
|
Donor lymphocyte infusions in amyloid light chain amyloidosis: induction of a "graft-versus-plasma cell-dyscrasia effect".
|
Haematologica
|
2009
|
0.75
|
|
211
|
Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study.
|
BMC Cancer
|
2014
|
0.75
|
|
212
|
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation.
|
Haematologica
|
2009
|
0.75
|
|
213
|
Hematopoietic stem cell transplantation (HSCT) for primary systemic vasculitis and related diseases.
|
Autoimmunity
|
2008
|
0.75
|
|
214
|
Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemia.
|
Eur J Haematol
|
2011
|
0.75
|
|
215
|
Summary of the 12th international symposium on recent advances in stem cell transplantation.
|
Exp Hematol
|
2004
|
0.75
|
|
216
|
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia.
|
Cancer Chemother Pharmacol
|
2014
|
0.75
|
|
217
|
Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndrome.
|
Eur J Haematol
|
2004
|
0.75
|
|
218
|
Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.
|
Stem Cells
|
2002
|
0.75
|
|
219
|
[Stem cells in hematology and oncology].
|
Med Klin (Munich)
|
2003
|
0.75
|
|
220
|
Autologous bone marrow transplantation in adult patients with acute lymphoblastic leukemia.
|
Leuk Lymphoma
|
2003
|
0.75
|
|
221
|
[Stem cell transplantation in primary systemic vasculitis].
|
Med Klin (Munich)
|
2003
|
0.75
|
|
222
|
Assessing hematopoietic (stem-) cell behavior during regenerative pressure.
|
Adv Exp Med Biol
|
2014
|
0.75
|
|
223
|
Novel constitutional t(2;12)(q21;q22) in a patient with t(9;22)-negative chronic myelocytic leukemia.
|
Cancer Genet Cytogenet
|
2003
|
0.75
|
|
224
|
Hepatitis B virus infection is associated with deletion of chromosome 8p in multiple myeloma.
|
Eur J Haematol
|
2012
|
0.75
|
|
225
|
Dose-intensive chemotherapy with stem cell support as a treatment strategy for bone and soft-tissue sarcomas.
|
Curr Stem Cell Res Ther
|
2006
|
0.75
|
|
226
|
Unrelated donor transplantation after reduced intensity conditioning as an approach for patients lacking related donors for allogeneic stem cell transplantation.
|
J Hematother Stem Cell Res
|
2003
|
0.75
|
|
227
|
Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
|
Haematologica
|
2002
|
0.75
|
|
228
|
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma.
|
Br J Haematol
|
2003
|
0.75
|
|
229
|
Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant.
|
Leuk Lymphoma
|
2014
|
0.75
|
|
230
|
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemia.
|
Eur J Haematol
|
2014
|
0.75
|
|
231
|
Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?
|
Support Care Cancer
|
2004
|
0.75
|
|
232
|
Law, ethics, religion, and clinical translation in the 21st century--a conversation with Anthony D. Ho. Interview by Majlinda Lako, Alan O. Trounson, and Susan Daher.
|
Stem Cells
|
2011
|
0.75
|
|
233
|
Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells.
|
Cell Tissue Res
|
2013
|
0.75
|